June 5 (Reuters) - CSL Ltd (CSL) :
- INJECTAFER APPROVED IN U.S. FOR TREATMENT OF IRON DEFICIENCY IN PATIENTS WITH HEART FAILURE
News: CSL CSL Ltd Says Injectafer Approved In U.S.
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$280.10 |
Change
1.780(0.64%) |
Mkt cap ! $135.3B | |||
| Open | High | Low | Value | Volume |
| $278.60 | $284.50 | $278.07 | $1.276B | 4.551M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 14269 | $280.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $281.00 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$283.77 |
Change
1.780 ( 2.08 %) |
||||
| Open | High | Low | Volume | ||
| $278.48 | $284.49 | $278.07 | 487345 | ||
| Last updated 15.59pm 31/05/2024 ? | |||||
| CSL (ASX) Chart |